Global Expansion CurifyLabs has clinical deployments in Europe and the US, recent leadership hires in the United States, and a strategic push with a U.S. Sales Director, signaling readiness for scale in international pharma and hospital networks.

Pet Healthcare Growth Recent launches focus on veterinary excipients and 3D printed medicines (CuraBlend Vet, Curablend Vet), presenting cross‑sell opportunities to veterinary clinics and pet pharmacies seeking personalized, palatable formulations.

Automated Personalization The CSS platform integrates GMP excipients, robotics, in‑process QC and a formulation library, enabling faster, compliant, patient‑specific compounding that appeals to pharmacy chains and hospital pharmacies aiming to increase throughput.

Design Recognition Award recognition at iF Design awards and ongoing media coverage highlight strong product differentiation and user experience, which can be leveraged in outreach to procurement and innovation teams seeking modern, design‑driven healthtech solutions.

Funding & Growth With revenue in the low to mid single digits and total funding of several millions, CurifyLabs is in an investment‑ready phase suitable for piloting scale programs with pharmacy groups, hospital systems, and potential OEM partnerships for automated compounding.